A mixed-methods study of cultural beliefs about dementia and genetic testing among Mexicans and Mexican-Americans at-risk for autosomal dominant Alzheimer's disease
- PMID: 31207006
- PMCID: PMC7500864
- DOI: 10.1002/jgc4.1133
A mixed-methods study of cultural beliefs about dementia and genetic testing among Mexicans and Mexican-Americans at-risk for autosomal dominant Alzheimer's disease
Abstract
Trials to prevent autosomal dominantly inherited Alzheimer's disease (ADAD) are critical and timely. However, cultural beliefs about AD and genetic testing may preclude informed consent and participation, especially among racial/ethnic minorities. This mixed-methods study examines cultural beliefs about AD and genetic screening among at-risk populations of Mexican heritage. We surveyed 86 Mexican and 37 Mexican-American family members of patients with ADAD and interviewed 18 respondents in Mexico to explore perceptions and knowledge regarding AD and genetic testing. While most respondents understood that AD is inherited in their families, they also had limited understanding of the genetic mechanisms behind AD. Many believed that AD is a normal part of aging or that it is a mental illness caused by bad habits. However, beliefs that AD is caused by a curse or God's will were uncommon. The interviews demonstrated that very few at-risk respondents understood their own risk for harboring the mutation causing AD in their family. Once informed, most expressed a strong interest in genetic testing, largely motivated by the desire to be better prepared for the development of AD. Health professionals treating and investigators enrolling members from families with ADAD cannot assume that they fully understand the nature of the illness; therefore, providers should provide comprehensive information about ADAD and genetic testing.
Keywords: Alzheimer's disease; Hispanic; Mexican; autosomal dominant; clinical trials; cultural beliefs; dementia; genetic; testing.
© 2019 National Society of Genetic Counselors.
Conflict of interest statement
Similar articles
-
Attitudes about involvement in hypothetical clinical trial protocols in Mexican and Mexican-American at risk for autosomal dominant Alzheimer's disease.Alzheimers Res Ther. 2022 Nov 15;14(1):173. doi: 10.1186/s13195-022-01114-4. Alzheimers Res Ther. 2022. PMID: 36380395 Free PMC article.
-
Suicidal ideation is common in autosomal dominant Alzheimer's disease at-risk persons.Int J Geriatr Psychiatry. 2020 Jan;35(1):60-68. doi: 10.1002/gps.5215. Epub 2019 Oct 22. Int J Geriatr Psychiatry. 2020. PMID: 31642105 Free PMC article.
-
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.Acta Neuropathol Commun. 2018 Nov 26;6(1):130. doi: 10.1186/s40478-018-0624-z. Acta Neuropathol Commun. 2018. PMID: 30477568 Free PMC article.
-
[Genetic counseling and testing for families with Alzheimer's disease].Neurol Neurochir Pol. 2004 Nov-Dec;38(6):495-501. Neurol Neurochir Pol. 2004. PMID: 15654674 Review. Polish.
-
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset.Expert Opin Biol Ther. 2018 Jan;18(1):25-35. doi: 10.1080/14712598.2018.1389885. Epub 2017 Oct 16. Expert Opin Biol Ther. 2018. PMID: 29037101 Review.
Cited by
-
Knowledge, perceptions, and feelings associated with Alzheimer's disease and related dementias: a qualitative study among middle-aged latinas residing in an underserved agricultural community in California.BMC Public Health. 2024 Oct 17;24(1):2865. doi: 10.1186/s12889-024-20195-4. BMC Public Health. 2024. PMID: 39420304 Free PMC article.
-
Research methodologies in genetic counseling: Grounded theory.J Genet Couns. 2025 Jun;34(3):e70060. doi: 10.1002/jgc4.70060. J Genet Couns. 2025. PMID: 40462574 Free PMC article.
-
Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.J Genet Couns. 2023 Feb;32(1):166-181. doi: 10.1002/jgc4.1632. Epub 2022 Oct 27. J Genet Couns. 2023. PMID: 36301246 Free PMC article.
-
Communicating PNPLA3 genetic risk status for NAFLD among Mexican-origin men.Front Public Health. 2023 Jan 4;10:1090101. doi: 10.3389/fpubh.2022.1090101. eCollection 2022. Front Public Health. 2023. PMID: 36684893 Free PMC article.
-
Understanding Healthcare Barriers for Latino/a/e/x Families with Alzheimer's Disease: Insights from Primary Care Provider interviews.medRxiv [Preprint]. 2024 Dec 12:2024.12.06.24318619. doi: 10.1101/2024.12.06.24318619. medRxiv. 2024. PMID: 39711732 Free PMC article. Preprint.
References
-
- Alonso ME, Ochoa A, Sosa AL, Rodriguez Y, Chavez M, Boll C, Yescas P, Macias R, Rasmussen A (2009) Presymptomatic diagnosis in Huntington’s Disease: The Mexican Experience. Genetic Testing and Molecular Biomarkers, 13(6): 717–720. - PubMed
-
- Alzheimer’s Association. (2018). Facts and Figures Accessed 17 April at: https://alz.org/documents_custom/2018-facts-and-figures.pdf
-
- Alzheimer Disease and Frontotemporal Dementia Mutation Database (2018). Accessed 17 April 2018 at: http://www.molgen.ua.ac.be/admutations
-
- Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, Rondon H, et al. (2001). A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA, 286(18):2257–2263. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials